Biotech had its second-in-a-row big rise on Thursday, with the Centient Biotech 200™ rising 46.87points, or 1.36%, to close at 3487.94. By contrast, the broader markets were relatively tame, neither exchange moving very far from unchanged. We discuss CuraGen, which got good news on a drug, plus which biotech stocks would have made you the most money today?
